These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. High disease activity of ankylosing spondylitis in the community before the introduction of tumour necrosis factor blockers. Hermann J, Müller T, Yazdani-Biuki B, Aringer M, Herold M, Ebner W, Ofner P, Graninger W. Ann Rheum Dis; 2007 Apr; 66(4):561-2. PubMed ID: 17360786 [No Abstract] [Full Text] [Related]
12. Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives? Kiltz U, Heldmann F, Baraliakos X, Braun J. Curr Opin Rheumatol; 2012 May; 24(3):252-60. PubMed ID: 22450391 [Abstract] [Full Text] [Related]
17. [Revision of the recommendations of the Commission on Pharmacotherapy of the German society for Rheumatology. Therapy with tumour necrosis factor blockers for inflammatory rheumatic illnesses]. Manger B, Michels H, Nüsslein HG, Schneider M, Sieper J, Kommission Pharmakotherapie der DGRh. Z Rheumatol; 2007 Feb; 66(1):72-5. PubMed ID: 17221253 [Abstract] [Full Text] [Related]